Company / Income Tax
Outlook Therapeutics, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$2.8K
FY2025
5-year range
-$3.6M / $501.5K
FY2021-FY2025
Trend
+100.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from -$4M to $2,800 over the past 6 years.
Based on SEC 10-K filings.
$2,800 in FY2025.
Increased from -$4M to $2,800 over the past 6 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, income tax increased 100.1% year-over-year.
- Peak income tax was recorded in FY2018.
- Lowest income tax in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.8K | +100.1% |
| FY2020 | -$3.4M | +6.5% |
| FY2019 | -$3.6M | -827.5% |
| FY2018 | $501.5K | +386.9% |
| FY2017 | $103.0K | +154.2% |
| FY2016 | -$190.1K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026